Oragenics, Inc. To Participate at the 15th Annual Traumatic Brain Injury Conference

UF Innovate | Accelerate graduate Oragenics, Inc., a biotechnology company advancing novel intranasal therapies for concussion and brain-related conditions, announced its participation in the 15th Annual Traumatic Brain Injury Conference, taking place May 5-6, 2025 in Boston, MA.

Hosted by Arrowhead Sci-Tech Conferences & Events, the Annual Traumatic Brain Injury Conference brings together global leaders from academia, industry, government, and the military to share the latest advancements in TBI research and clinical care. The event provides a platform for cross-sector collaboration on diagnosis, treatment, and long-term outcomes for TBI survivors.

Read more about Oragenics, Inc. To Participate at the 15th Annual Traumatic Brain Injury Conference.